Recent News

By Category: Countermeasures

11 Million for Buying Vaccines for Foot and Mouth Disease

(AllAfrica.com) Planning and International Cooperation Minister Fayza Abul-Naga decided to allocate the sum of EGP 11 million as urgent support to the General Authority for veterinary services to buy two million vaccine doses for foot and mouth disease (FMD).

April 10, 2012
| Filed under North America, Agriculture, and Countermeasures
Share

U.S. to Offer Anthrax Vaccine to First Responders on Trial Basis

(Global Security Newswire) The Obama administration is preparing to make unused federal stocks of anthrax vaccine available to certain nonmilitary emergency personnel in a trial effort that could lead to wider distribution of the countermeasure to first responders. The initiative would offer select state and local officials the option to accept a federally funded course Read More »

April 10, 2012
| Filed under North America and Countermeasures
Share

Fast-Acting Bioagent Detector Developed in Wales

(Global Security Newswire) The Welsh branch of a Germany security company has led development of a portable device that within minutes could reveal a bioterror agent that had been introduced into drinking water, the Cardiff Western Mail reported on Saturday. “Growing concern about drinking water safety and the highly distributive nature of water supplies highlights Read More »

April 10, 2012
| Filed under Europe, Biotechnology, Bioterrorism, Countermeasures, Public Health, and Research
Share

Tackling Bioterrorism

(The Diplomat) The United States is vulnerable to an attack that could kill hundreds of thousands. But the big threat might not come from a nuclear device falling into the wrong hands, and certainly not from a brigade of suicide bombers. Instead, argues James Glassman in an article Forbes article this week, “terrorists could spray Read More »

April 9, 2012
| Filed under Asia/Pacific, North America, South Asia, Bioterrorism, Countermeasures, International, and Research
Share

Bioterrorism threat spurs authorities to invoke animal rule for J&J antibiotic

(MedCity News) An FDA advisory panel this week agreed that studies using monkeys demonstrated Levaquin’s effectiveness in treating pneumonic plague. The FDA can invoke the animal rule, which allows evidence to support the approval to be based entirely on animal studies, to provide a regulatory pathway when human studies aren’t possible, the paper said.